Podcast Episode 16: CGM Insights - Unveiling Cutting-Edge Clinical Evidence for Type 2 Diabetes Management
Sponsored by 
Guest Speaker: Maggie Crawford, MPH, PhD
Real-time real talk is intended for healthcare professionals in the US.
In this episode, host Cher Pastore speaks to Maggie Crawford, senior manager of translational and behavioral data science at Dexcom, to discuss findings from a few studies Dr. Crawford was presenting at ADA.
The first study, titled "Exploring the Impact of CGM on Perceived Control and Non-Intensive Insulin Treated Type Two Diabetes", explored how CGM use influenced individuals' perceptions of control over their diabetes. Participants monitored their glucose levels with Dexcom's CGM system over a three month period with no behavioural support.
The second study investigated the impact of Dexcom's G6 real-time CGM on glucose metrics, self-reported body weight, and psychosocial health among customers living with type two diabetes and taking basal insulin.
Presenters
Margaret Crawford, MPH, PhD
Maggie has a PhD public health, focusing on health behavior, and also earned a masters in public health in epidemiology. Maggie's personal and career goal is to help people understand their physiology and behaviors to help them feel in control of managing their health.